A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer
Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The primary aim is to evaluate the safety (Phase I components) of administering bexarotene
(Targretin®, LGD1069) oral capsules in combination with two Taxol® and carboplatin
(Paraplatin®) schedules to patients with stage IIIB and IV non-small cell lung cancer. This
study will also evaluate the preliminary efficacy (Phase II component) of bexarotene oral
capsules in combination with the weekly Taxol® schedule and carboplatin in these patients.